CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.545
EU - Europa 8.903
AS - Asia 6.171
SA - Sud America 874
Continente sconosciuto - Info sul continente non disponibili 374
AF - Africa 184
OC - Oceania 15
Totale 28.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.172
RU - Federazione Russa 3.030
SG - Singapore 2.340
GB - Regno Unito 2.153
CN - Cina 1.956
IT - Italia 1.089
BR - Brasile 679
DE - Germania 644
SE - Svezia 484
VN - Vietnam 475
HK - Hong Kong 448
FR - Francia 438
IE - Irlanda 393
FI - Finlandia 266
BD - Bangladesh 197
KR - Corea 185
CA - Canada 169
IN - India 123
TR - Turchia 107
JP - Giappone 102
UA - Ucraina 91
AR - Argentina 75
NL - Olanda 74
MX - Messico 54
PL - Polonia 44
ZA - Sudafrica 44
NG - Nigeria 42
ID - Indonesia 40
ES - Italia 39
BE - Belgio 31
AT - Austria 30
CO - Colombia 30
EC - Ecuador 29
IQ - Iraq 25
CR - Costa Rica 24
RO - Romania 20
GT - Guatemala 19
SA - Arabia Saudita 19
UZ - Uzbekistan 19
VE - Venezuela 18
NI - Nicaragua 17
CW - ???statistics.table.value.countryCode.CW??? 16
EG - Egitto 16
HN - Honduras 15
SV - El Salvador 15
IR - Iran 14
PK - Pakistan 14
CL - Cile 13
IL - Israele 13
JM - Giamaica 13
PR - Porto Rico 13
MA - Marocco 12
PE - Perù 12
AU - Australia 11
KE - Kenya 11
PH - Filippine 11
PY - Paraguay 11
SC - Seychelles 11
BJ - Benin 10
AE - Emirati Arabi Uniti 9
TT - Trinidad e Tobago 9
QA - Qatar 8
GR - Grecia 7
LT - Lituania 7
MY - Malesia 7
NP - Nepal 7
TN - Tunisia 7
AZ - Azerbaigian 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
EE - Estonia 6
ET - Etiopia 6
JO - Giordania 6
SN - Senegal 6
AL - Albania 5
AM - Armenia 5
NO - Norvegia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
HR - Croazia 4
KG - Kirghizistan 4
LB - Libano 4
PA - Panama 4
PT - Portogallo 4
TG - Togo 4
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
CU - Cuba 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UY - Uruguay 3
Totale 27.663
Salva come PNG Salva come JPEG
Città #
Southend 1.904
Dallas 1.636
Ashburn 1.550
Singapore 1.277
San Jose 1.039
Moscow 1.017
Chandler 942
Jacksonville 465
Hong Kong 436
Council Bluffs 416
Dublin 391
Woodbridge 390
Beijing 316
Ann Arbor 315
Verona 292
The Dalles 275
Houston 226
Los Angeles 191
New York 181
Princeton 160
Lawrence 159
Wilmington 156
Ho Chi Minh City 151
Jinan 142
Bologna 134
Redmond 128
Shenyang 127
Nanjing 121
Hanoi 109
Santa Clara 101
Helsinki 97
Buffalo 92
Milan 91
Tokyo 90
Munich 83
São Paulo 78
Hebei 73
Tianjin 72
Rome 63
Redondo Beach 57
Zhengzhou 56
Chicago 55
Changsha 51
Haikou 51
Ningbo 51
Columbus 49
Sindelfingen 43
Taizhou 43
Hangzhou 42
Orem 42
Atlanta 41
Guangzhou 41
Toronto 41
Abuja 40
San Francisco 40
Montreal 38
Nanchang 38
Taiyuan 38
Denver 36
Warsaw 36
London 34
Redwood City 34
Jiaxing 32
Brooklyn 31
Phoenix 31
Seattle 30
Washington 27
Brussels 26
Norwalk 26
Turku 26
Boardman 24
Johannesburg 24
Lanzhou 24
Fuzhou 23
Hyderabad 23
Amsterdam 22
Da Nang 22
Düsseldorf 21
Manchester 21
Chennai 20
Naples 20
Rio de Janeiro 20
Dearborn 19
Frankfurt am Main 19
Mexico City 19
North Bergen 19
Vienna 19
Brasília 18
Charlotte 18
Poplar 18
Stockholm 18
Tashkent 18
Haiphong 17
Lancaster 17
Sanayi 17
Venice 17
Belo Horizonte 16
Managua 16
San José 16
Willemstad 16
Totale 17.293
Salva come PNG Salva come JPEG
Nome #
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 413
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 378
Teriparatide and denosumab combination therapy and skeletal metabolism 362
A new instrument for the screening of psoriatic arthritis among psoriatic patients 348
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 268
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 265
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 255
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 242
Bone metabolism in patients with anorexia nervosa and amenorrhoea 242
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 237
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 233
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 227
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 224
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 224
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 219
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 219
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 219
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 218
Rheumatoid Arthritis and heart disease risk factors and ultrasound findings 217
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 216
Bone involvement and osteoporosis in mastocytosis. 216
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 216
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 213
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 210
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 210
Bone involvement in patient with clonal mast cell disorders 208
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 208
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 206
Prevalence and incidence of rheumatoid arthritis in Italy. 202
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 201
Could γ\δ T-cells explain zoledronic acid adverse events? 199
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 199
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 199
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 197
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 194
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 194
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 193
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 192
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 190
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 190
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 189
Osteopetrosi 187
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 185
The obesity paradox and osteoporosis 185
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 185
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 184
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 182
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 180
Sclerostin and DKK1 in primary hyperparathyroidism. 179
DXA bone mineral density in males: retrospective study in real life. 176
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 176
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 175
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 174
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 174
Prevalence of osteoporosis in patients affected by mastocytosis 174
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 174
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 174
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 173
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 172
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 171
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 171
Effects of denosumab on peripheral lymphocyte subpopulations 169
Vitamin D levels in patients with psoriasis with or without arthritis 168
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 168
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 167
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 167
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 166
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 165
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 164
Development and First Validation of a Disease Activity Score for Gout 164
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 164
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 163
Periostin: The bone and beyond 163
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 162
Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review 162
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 160
Focal bone involvement in inflammatory arthritis: the role of IL17 159
Surgical Treatment of Symptomatic Aortic Aneurysm in a Patient with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: Case Report and Review of the Literature 159
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 158
Drug-induced osteonecrosis of the jaw: the state of the art 158
Vitamin D status in patients with chronic plaque psoriasis 157
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study 157
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 156
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 154
Ruolo della vitamina D 154
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis 153
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 152
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 152
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 151
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 150
Rheumatoid arthritis, γδ T cells and bisphosphonates 149
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 149
Effects of secukinumab on serum adipocytokines: preliminary data 147
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 147
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 147
Insight into the WNT system and its drug related response. 146
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 146
Osteoporosi ed attività sportiva. 145
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 145
Enthesitis of the hands in psoriatic arthritis: an ultrasonographic perspective 144
Totale 19.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.120
article - articoli 93.810
book - libri 0
conference - conferenze 715
curatela - curatele 0
other - altro 595
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022693 0 0 0 0 54 29 24 64 81 24 85 332
2022/20232.680 190 288 241 490 213 647 45 145 290 30 76 25
2023/20241.250 54 113 107 152 158 180 60 126 6 37 189 68
2024/20253.148 151 221 152 492 145 111 162 147 467 261 282 557
2025/202611.493 717 504 1.655 1.651 2.538 710 1.059 552 787 612 266 442
2026/20272.263 189 326 489 1.196 63 0 0 0 0 0 0 0
Totale 28.066